Clinical trial · Interventional
MAAT For Young Adult Cancer Survivors
Modifying Memory and Attention Adaptation Training (MAAT) For Young Adult Childhood Cancer Survivors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical trial is to pilot-test a modified version of telehealth-delivered Memory and Attention Adaption Training (MAAT) that is tailored to young adult childhood cancer survivors (ages 18-39; MAAT-YS) with cancer-related cognitive impairment (CRCI). MAAT-YS consists of 8 weekly visits (45-minutes in duration) and participants use a survivor workbook and complete homework between visits. Participants in this single-group pilot trial (N=9) will complete online self-report measures of cognitive symptoms, quality of life, treatment satisfaction and a brief online neuropsychological test battery at baseline and post-MAAT-YS timepoints.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MAAT-YS | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- MAAT-YS Group
- description
- This group will be treated with the MAAT-YS cognitive-behavioral therapy.
- interventionNames
- Behavioral: MAAT-YS
Primary outcomes (5)
- measure
- Functional Assessment of Cancer Therapy-Cognitive (FACT-Cog) v.3. Perceived Cognitive Impairments Scale (PCI)
- timeFrame
- Baseline to Post-Treatment (after 8 weekly telehealth MAAT-YS visits)
- description
- The PCI assesses perceived cognitive function of participants within a timeframe of the previous 7 days. It consists of 18 items with a 5-point Likert-type rating of 0 (Never) to 4 (Several times a day) with a scoring range of 0-72. Scoring instructions indicate items are reverse scored, such that higher scores denote better perceived cognitive function, lower scores, poorer cognitive function.
- measure
- CNS Vital Signs (CNSVS) Online Neuropsychological Test Battery (1) Verbal Memory (VBM) (recognition memory for words)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 39 Years
Show eligibility criteria text
Inclusion Criteria: 1. Adults aged 18-39 2. Diagnosed prior to 18 years of age with non-CNS solid tumor or leukemia/lymphoma without known CNS involvement 3. At least 1 year after completion of treatment including chemotherapy, cancer-free 4. English fluent 5. Memory or other cognitive problems attributed to cancer and/or cancer treatment 6. Score of \<10 on the FACT-Cog Impact on Quality of Life Scale 7. Willing to use telehealth with internet access 8. Willing to provide informed consent to participation Exclusion Criteria: 1. Severe non-cancer brain injury such as severe traumatic brain injury, stroke or toxic injury causing memory impairments; 2. Currently meeting Diagnostic and Statistical Manual-5 (DSM-5) criteria for a severe psychiatric disorder, including substance abuse, mood, anxiety, or psychotic disorders, as assessed by the PRIME-MD; 3. Scoring 3 or below on the 6-item cognitive screen designed to detect severe memory disorders;59 4. Severe uncorrected sensory impairment (severe hearing or visual impairment).
References
Publications (0)
Data not yet available